Two Johns Hopkins faculty members have been elected to the National Academy of Medicine

Johns Hopkins University faculty members Christopher G. Chute and Jeffrey D. Rothstein are among 100 scholars recently elected to the National Academy of Medicine, announced today during the NAM’s annual meeting in Washington, DC.

An independent organization of leading scholars from many scientific fields including health, medicine, and the natural, social, and behavioral sciences, NAM works with the National Academy of Sciences and the National Academy of Engineering to provide appropriate advice for the public and international scientific communities.

Membership in the NAM is considered one of the highest honors in the fields of health and medicine. Since NAM’s founding in 1970, the work and advocacy of its members has shaped health research, practice, and policy that improves health and health outcomes worldwide. New members are elected by current members in a selective process that recognizes people who have made significant contributions to the development of medical science, health care and public health. NAM now has over 2,400 members.

More on this year’s National Academy of Medicine selections from Johns Hopkins:

Christopher Chute is a Bloomberg Distinguished Professor of Health Informatics. He also holds basic science appointments at the Johns Hopkins schools of Medicine, Public Health and Nursing. He is the chief information officer for Johns Hopkins Medicine, associate director of the Center for Clinical and Translational Research at Johns Hopkins, co-chair of the research sub-council of the Johns Hopkins Data Trust, and head of the division of biomedical informatics and data science at the Division of General Internal Medicine.

NAM recognized Chute for his work on how clinical data is represented to support data discovery and discovery science in the learning health system, focusing on ontologies, groups and data. real world. He led the 11th update of the World Health Organization’s International Group on Diseases, which changed the system of the century to support data science, and he is in charge of many large national areas of electronic health records to advance outcomes research. His work has led to many discoveries that have changed the practice of medicine. Chute joined the Johns Hopkins faculty in 2015.

Jeffrey Rothstein is a professor of neurology and neuroscience at the Johns Hopkins University School of Medicine. Also at Johns Hopkins, he is the founder and director of the Robert Packard Center for ALS (amyotrophic lateral sclerosis) Research, the director of the Brain Science Institute, and the founder and co-founder of the ALS clinic. He is also a member and former executive director of the American Academy of Physicians, a prestigious medical organization whose members are physicians with specialized degrees in basic or translational biomedical research.

His lab first discovered that excitotoxicity may be a common pathophysiological process in transient ALS, leading to the use of the drug riluzole as an ALS treatment. Rothstein discovered key pathways underlying familial and sporadic ALS, including excitotoxicity, astrocyte dysfunction, oligodendroglial dysfunction, and the role of nuclear transporters and nucleocytoplasmic transporters in familial ALS and part time. The author of more than 360 research articles on ALS pathophysiology and basic neuroscience, Rothstein is also the founder and director of the ALS Response program, which combines longitudinal clinical data, smartphone home data collection, and generation of induced pluripotent stem (iPS) neurons from more than 1,000 ALS patients in the US, and their comprehensive analyses, leading to a data collection of 6 million biological and clinical data of per patient.